Gm-csf inhibiting oligopeptides
CA 2060699 A1 · Owner: Bursuker, Isia · Inventors: Bursuker, Isia; Greenfield, Robert S.; Braslawsky, Gary S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided are oligopeptides which are capable of inhibiting the biological activity of a granulocytemacrophage colony stimulating factor ("GN-CSF"). These oligopeptides are useful for alleviating undesirable biological effects mediated by GM-CSF. In particular, the oligopeptides are useful for inhibiting the growth of a GM-CSF dependent neoplastic disease. Also provided are formulations and methods for using the oligopeptides of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 5, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 5, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 5, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.